Company news
Osteopore Ltd. news in 2026
Osteopore Ltd.'s news releases, calls and decks from 2026, newest first.
OSX focuses on Ortho line in Singapore via direct selling
November 1, 2026
Activities Report September 2026 and Appendix 4C
October 30, 2026
Resignation and appointment of Company Secretary
October 2, 2026
OSX secures market access to Thailand orthopaedic market
September 8, 2026
Half Yearly Report and Accounts
August 31, 2026
OSX strikes orthopaedic deal for 5 Middle East countries
August 5, 2026
Details of Auditor Appointment/Resignation
August 3, 2026
OSX completes first Hainan custom orthopaedic implant
August 2, 2026
Activities Report June 2026 and Appendix 4C
July 30, 2026
OSX secures Hainan FDA approval for orthopaedic devices
May 25, 2026
Activities Report March 2026 and Appendix 4C
April 29, 2026
Further Drawdown of T2 of the Redeemable Convertible Notes
March 26, 2026
Clarification - agreement for injectable regen bone filler
March 12, 2026
OSX signs agreement for injectable regenerative bone filler
March 11, 2026
OSX secures distribution for autologous dentin bone graft
March 2, 2026
Appendix 4E Preliminary Final Report
February 27, 2026
Drawdown of Tranche 2 of the Redeemable Convertible Notes
February 16, 2026
OSX secures Latin America deal for craniofacial distribution
February 12, 2026
Osteopore Secures Latin America Deal For Craniofacial Distribution
February 12, 2026
Further Drawdown of T1 of the Redeemable Convertible Notes
February 6, 2026
Activities Report December 2025 and Appendix 4C
January 29, 2026
Clarification - agreement for orthopaedic products in HK
January 22, 2026
OSX strikes agreement for orthopaedic products in Hong Kong
January 21, 2026
Clarification - OSX partner Chinese dental & maxillofacial
January 16, 2026
OSX partners up for Chinese dental & maxillofacial market
January 15, 2026